These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3922094)

  • 1. Determination of free valproic acid concentrations using the Amicon Micropartition MPS-1 Ultrafiltration System.
    March C; Blanke RV
    Ther Drug Monit; 1985; 7(1):115-20. PubMed ID: 3922094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Amicon Centrifree micropartition system with the Sartorius SM 13249E Centrisart I device to determine protein free phenytoin concentrations.
    Zysset T; Zeugin T
    Ther Drug Monit; 1986; 8(3):346-51. PubMed ID: 3529518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscale ultrafiltration technique for determining free drug in 50-microL serum samples.
    Wittfoht W; Duwe K; Kuhnz W; Nau H
    Clin Chem; 1984 Jun; 30(6):878-9. PubMed ID: 6426820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Influence of Plasma Albumin Concentration on the Analysis Methodology of Free Valproic Acid by Ultrafiltration and Its Application to Therapeutic Drug Monitoring.
    Zhang ZQ; Dong WC; Yang XL; Zhang JF; Jiang XH; Jing SJ; Yang HL; Jiang Y
    Ther Drug Monit; 2015 Dec; 37(6):776-82. PubMed ID: 26035137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved ultrafiltration method for determining free testosterone in serum.
    Vlahos I; MacMahon W; Sgoutas D; Bowers W; Thompson J; Trawick W
    Clin Chem; 1982 Nov; 28(11):2286-91. PubMed ID: 7127776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of five platinum compounds. Comparison of two ultrafiltration systems.
    van der Vijgh WJ; Klein I
    Cancer Chemother Pharmacol; 1986; 18(2):129-32. PubMed ID: 3791557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simplified ultrafiltration method for determination of serum free cortisol.
    MacMahon W; Thompson J; Bowers W; Sgoutas D
    Clin Chim Acta; 1983 Jul; 131(3):171-84. PubMed ID: 6883713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of tube type, storage time, and temperature on the total and free concentration of valproic acid.
    Tarasidis CG; Garnett WR; Kline BJ; Pellock JM
    Ther Drug Monit; 1986; 8(3):373-6. PubMed ID: 3092409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equilibrium dialysis, ultrafiltration, and ultracentrifugation compared for determining the plasma-protein-binding characteristics of valproic acid.
    Barré J; Chamouard JM; Houin G; Tillement JP
    Clin Chem; 1985 Jan; 31(1):60-4. PubMed ID: 3917383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafiltration using the Amicon MPS-1 for assessing methadone plasma protein binding.
    Wilkins JN; Ashofteh A; Setoda D; Wheatley WS; Huigen H; Ling W
    Ther Drug Monit; 1997 Feb; 19(1):83-7. PubMed ID: 9029753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ultrafiltrate volume on determination of free phenytoin concentration.
    McMillin GA; Juenke J; Dasgupta A
    Ther Drug Monit; 2005 Oct; 27(5):630-3. PubMed ID: 16175137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and plasma for total and free anticonvulsant drug analyses: effects on EMIT assays and ultrafiltration devices.
    Godolphin W; Trepanier J; Farrell K
    Ther Drug Monit; 1983; 5(3):319-23. PubMed ID: 6415872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid-ketoconazole interaction in normal, hypoalbuminemic, and uremic sera: lack of interaction in uremic serum caused by the presence of inhibitor.
    Dasgupta A; Luke M
    Ther Drug Monit; 1997 Jun; 19(3):281-5. PubMed ID: 9200768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of free desipramine in serum by ultrafiltration with immunoassay.
    Hursting MJ; Clark GD; Raisys VA; Miller SJ; Opheim KE
    Clin Chem; 1992 Dec; 38(12):2468-71. PubMed ID: 1458586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo microdialysis for pharmacokinetic investigations: a plasma protein binding study of valproate in rabbits.
    Nakashima M; Takeuchi N; Hamada M; Matsuyama K; Ichikawa M; Goto S
    Biol Pharm Bull; 1994 Dec; 17(12):1630-4. PubMed ID: 7735208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients.
    Hermida J; Tutor JC
    J Pharmacol Sci; 2005 Apr; 97(4):489-93. PubMed ID: 15840952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Simple and Rapid Method to Measure Free Fraction of Valproic Acid in Plasma Using Ultrafiltration and Ultra High Performance Liquid Chromatography-Mass Spectroscopy: Application to Therapeutic Drug Monitoring.
    Xu S; Chen Y; Zhao M; Zhao L
    Ther Drug Monit; 2017 Oct; 39(5):575-579. PubMed ID: 28700449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ultrafiltration devices for assessing theophylline protein binding.
    Blanchard J; Harvey S
    Ther Drug Monit; 1990 Jul; 12(4):398-403. PubMed ID: 2396314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation of canine serum magnesium.
    Schenck PA
    Vet Clin Pathol; 2005 Jun; 34(2):137-9. PubMed ID: 15902665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of drugs over whole blood: I. The transport function of whole blood for valproate.
    Driessen O; Treuren L; Meijer JW
    Ther Drug Monit; 1989; 11(4):384-9. PubMed ID: 2500756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.